CWRU to Develop Artificial Intelligence for Oral Cancer Treatment
Researchers at Case Western Reserve University (CWRU) and partners in the United States and India said they are applying the investigative and predictive.
AI in Dentistry
Industry News
Combination Therapy Improves Head and Neck Cancer Treatment
Researchers at the UCLA Jonsson Comprehensive Cancer Center and UCLA School of Dentistry have identified a potential new combination therapy to treat advanced.
Industry News
Preoperative Immunotherapy Triggers Encouraging Response in Oral Cancers
Immunotherapy given before other treatments for oral cavity cancers may elicit an immune response that shrinks tumors, which could provide long-term benefits for.
Industry News
Enrollment Continues in Study of Oral Mucositis Medication
Soligenix is actively enrolling patients in a Phase 3 multinational, double-blind, placebo-controlled clinical trial of SGX942, or dusquetide, for the treatment of oral mucositis.
Industry News
Checkpoint Inhibitor Increases Head and Neck Cancer Survival Time
The checkpoint inhibitor pembrolizumab (Keytruda) offers patients with advanced head and neck cancers longer survival time, according to researchers led by the Yale.
Industry News
Algorithms Accurately Predict Oral Cancer Survival Chances
Artificial intelligence algorithms developed by the University of Warwick Department of Computer Science in conjunction with other institutions can predict the chance of surviving.
Industry News
Traits Connected With Better Outcomes in HPV-Linked Head and Neck Cancer Identified
Using a new blood test that’s in development, researchers at the University of North Carolina (UNC) Lineberger Comprehensive Cancer Center have identified characteristics.
Industry News
Research Uncovers Microbiome’s Role in Oral Mucositis
Researchers at the University of Connecticut School of Dental Medicine say they are a step closer to understanding the root causes of oral.
Industry News
Topical Anesthetic Improves Oral Mucositis Pain Treatment
Researchers at the University of Connecticut are collaborating with drug design firm Cellix Bio to develop a long-acting topical anesthetic that may replace.
Industry News
Grant to Support Research into Light Therapy for Treating Oral Pain
University at Buffalo (UB) researchers have received part of a $1.5 million grant to investigate light therapy as a replacement for prescription opioids.
